Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

The discovery sheds light on an important tool for fighting drug-resistant strains of herpes simplex virus, or HSV, and points to new pathways for treating herpesviruses and other kinds of DNA viruses (those that have DNA as their genetic material and can replicate inside host cells).

The study is published in Cell.